Patent · US Active

Substituted 1,4,8-triazaspiro[4,5]decan-2-one compounds

US7560468B2 · kind B2 · utility

13Cited by
1References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 22, 2006
Grant dateJul 14, 2009
Priority date
Expiry dateJan 19, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel 1,4,8-triazaspiro[4,5]decan-2-one compounds corresponding to formula Iprocesses for the preparation thereof, related methods of treatment and pharmaceutical formulations containing such compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.